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University of Washington, Seattle, WA, USA and 13) London School of Hygiene and Tropical Medicine, London, UKAbstractStaphylococcus argenteus is a globally distributed cause of human infection, but diagnostic laboratories misidentify this as Staphylococcus aureus.
We determined whether there is clinical utility in distinguishing between the two. A prospective cohort study of community-onset invasive
staphylococcal sepsis was conducted in adults at four hospitals in northeast Thailand between 2010 and 2013. Of 311 patients analysed, 58
(19%) were infected with S. argenteus and 253 (81%) with S. aureus. Most S. argenteus (54/58) were multilocus sequence type 2250. Infection
with S. argenteus was more common in males, but rates of bacteraemia and drainage procedures were similar in the two groups. S. argenteus
precipitated signiﬁcantly less respiratory failure than S. aureus (5.2% versus 20.2%, adjusted OR 0.21, 95% CI 0.06–0.74, p 0.015), with a
similar but non-signiﬁcant trend for shock (6.9% versus 12.3%, adjusted OR 0.46, 95% CI 0.15–1.44, p 0.18). This did not translate into a
difference in death at 28 days (6.9% versus 8.7%, adjusted OR 0.80, 95% CI 0.24–2.65, p 0.72). S. argenteus was more susceptible to
antimicrobial drugs compared with S. aureus, and contained fewer toxin genes although pvl was detected in 16% (9/58). We conclude
that clinical differences exist in association with sepsis due to S. argenteus versus S. aureus.
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p://dx.doi.org/10.1016/j.cmi.2016.01.008IntroductionStaphylococcus argenteus is a genetically divergent lineage of
Staphylococcus aureus that received formal taxonomic classiﬁ-
cation in 2014 [1]. S. argenteus is mis-identiﬁed as S. aureus iniology and Infectious Diseases
.0/)
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tests [2–4]. Multilocus sequence typing (MLST) makes a clear
distinction between the two species, but the original PCR
primers for S. aureus failed to amplify two of the seven loci in
S. argenteus [2,5,6] and such isolates were often excluded by
default. Although several of the earliest descriptions of
S. argenteus were associated with remote communities [2–4],
cumulative publications have since suggested that S. argenteus
is globally distributed. This includes its isolation from humans
or animals in Thailand, Cambodia, Indonesia, Fiji, New Zealand,
Mayotte, Trinidad and Tobago, with additional evidence from
the MLST database of its presence in Europe and Africa
[2–12].
Discovering the existence of this new pathogenic species
results in the need to determine whether S. argenteus and
S. aureus should be distinguished apart in routine practice. This
might be necessary if S. argenteus infection is associated with
different clinical manifestations, severity or outcome, and/or
requires different antimicrobial regimens. Data on clinical fea-
tures of human S. argenteus infection are limited, but a study
that deﬁned the frequency of S. argenteus in three different
clinical collections in northern Australia reported that this was
predominantly associated with skin and soft-tissue infections,
but rarely with bacteraemia [13]. S. argenteus has been reported
to be more susceptible to oxidative stress and neutrophil killing
in vitro, and less virulent in murine sepsis and skin infection
models compared with S. aureus [13]. This raises the possibility
that human S. argenteus infection may be associated with a
milder course. Comparison between ten patients with invasive
S. argenteus infection and 236 patients with invasive S. aureus
infection reported that morbidity and death were comparable
[6], but this study was underpowered. The presence of viru-
lence genes in S. argenteus has not been subjected to detailed
investigation. Several studies have reported that S. argenteus is
negative for genes encoding Panton–Valentine leukocidin (PVL)
[3,4,7,8,14,15], although a recent case report of two patients
with PVL-positive S. argenteus infection [11] indicates that this
species may acquire virulence factors. One study also detected
the gene encoding staphylococcal enterotoxin B in all
S. argenteus isolates cultured from villagers in the Amazonian
forest [4].
Here, we describe a prospective, multicentre study of inva-
sive staphylococcal infection that was initially reported by
diagnostic laboratories to be due to S. aureus, in which around
one-ﬁfth of isolates were re-identiﬁed as S. argenteus. This
allowed a comparison of patient characteristics and demog-
raphy, features of infection and outcome, antimicrobial resis-
tance proﬁles, and the presence of selected putative virulence
determinants.© 2016 The Authors. Published by Elsevier Ltd on behalf of Euro
This is an oMethodsStudy setting and design
A prospective cohort observational study of community-onset
invasive staphylococcal infection was conducted in patients with
sepsis at four hospitals across northeast Thailand between
March 2010 and December 2013. Study sites were Sunpa-
sitthiprasong Hospital, Ubon Ratchathani; Udon Thani Hospital,
Udon Thani; Srinagarind Hospital, Khon Kaen; and Khon Kaen
Hospital, Khon Kaen. Potential study patients were identiﬁed by
daily screening at each hospital diagnostic microbiology labo-
ratory for clinical samples that grew a pure culture identiﬁed by
the routine microbiology laboratory as S. aureus. Invasive
infection was deﬁned as the isolation of S. aureus from a sample
taken from a normally sterile site. Inclusion criteria were as
follows: age at least 14 years (age of admission to adult wards),
community-onset infection (positive culture taken within 2 days
of hospital admission, or after 2 days when sampling was
delayed from a patient admitted with suspected infection), and
at least two of four systemic inﬂammatory response syndrome
criteria met within 48 h of culture. These criteria are: (a)
temperature >38°C or <36°, (b) heart rate >90 beats/min, (c)
respiratory rate >20 breaths/min, PCO2 <32 mmHg, or a
requirement for mechanical ventilation, and (d) white blood
count >12 000 cells/mL or <4000 cells/mL, or >10% band
forms [16]. Exclusion criteria were other active co-infections,
therapeutic immunosuppression with high-dose steroids or
chemotherapy, and pregnancy. Patients were enrolled after
providing written informed consent.
Clinical information was obtained from the medical records.
Patients were followed until hospital discharge, during which
time antimicrobial therapy, surgical drainage procedures, the
development of shock requiring vasopressors or inotropes, or
respiratory failure requiring mechanical ventilation were recor-
ded. Mortality was ascertained 28 days from the day of admis-
sion. For patients discharged before 28 days, outcome was
determined through telephone follow up. Patient residence was
deﬁned using http://mondeca.com/index.php/en/?option=com_
content&view=article&id=206&Itemid=752, and the co-
ordinates were mapped using ARCGIS software (https://www.
arcgis.com). Ethical approval was obtained from the following
Ethical and Scientiﬁc Review committees: Faculty of Tropical
Medicine, Mahidol University (approval no. MUTM 2011-007-
01); Sunpasitthiprasong Hospital, Ubon Ratchathani (approval
no. 004/2553); Udon Thani Hospital, Udon Thani (approval no.
0027.102/2349); Khon Kaen Hospital, Khon Kaen; and Faculty of
Medicine (Srinagarind Hospital), Khon Kaen University, Khon
Kaen, Thailand (approval no. HE541113).pean Society of Clinical Microbiology and Infectious Diseases, CMI, 22, 458.e11–458.e19
pen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Following initial isolation and identiﬁcation by the routine
diagnostic laboratories, the staphylococcal isolate that trig-
gered enrolment for each patient was stored in trypticase soy
broth with 15% glycerol at –80°C before further character-
ization. Twelve antimicrobial drugs were selected for suscep-
tibility testing based on their prescription at least once for the
study cohort. These were cefoxitin, clindamycin,
trimethoprim-sulfamethoxazole, erythromycin, fosfomycin,
fusidic acid, gentamicin, levoﬂoxacin, oxacillin, penicillin, tige-
cycline and vancomycin. Antimicrobial susceptibility proﬁles
were determined and interpreted according to the CLSI
guidelines (M100-S24) [17], with the exception of fusidic acid
and tigecycline, which were tested using the EUCAST guide-
lines (Version 4.0, 2014; http://www.eucast.org). Zones of in-
hibition were interpreted using M100-24, and isolates were
reported as susceptible, intermediate, or resistant. Isolates
were initially assigned as MRSA based on the cefoxitin disk
diffusion assay [17], and conﬁrmed using PCR to detect the
mecA gene.
Staphylococcus aureus genotyping and detection of
putative virulence genes
Pulsed-ﬁeld gel electrophoresis (PFGE) was performed using
the SmaI restriction enzyme (New England Biolabs, UK) [18].
Banding patterns were analysed using BIONUMERICS software
version 6.01 (Applied Maths, Sint-Martens-Latem, Belgium) as
described [19]. A similarity coefﬁcient of 80% was used to
deﬁne PFGE types [18]. DNA was extracted and MLST was
performed as described elsewhere [2,6,20]. Sequence types
(ST) were assigned using the MLST database (www.mlst.net)
[20]. Phylogenetic analysis of concatenated MSLT data was
performed using CLUSTALW for the alignment and the maximum
likelihood method for construction of the phylogenetic tree in
MEGA version 6. Two multiplex PCR assays were used to
detect the presence of virulence and other genes (assay 1 for
tst, eta, etb, sea, seb, sec, sed, see [21], assay 2 for mecA and pvl)
[22].
Statistical analysis
Continuous variables are reported as mean and standard de-
viation for normally distributed data or median and inter-
quartile range for non-normally distributed data. Univariable
analyses were performed with logistic regression. Multivariable
analyses were performed with multiple logistic regression,
adjusting as appropriate for age, sex, co-morbidities, centre,
delayed initiation of anti-staphylococcal antibiotics and surgical
drainage of infection. A co-morbidity index (possible range one
to ten) assigned one point for each of the following pre-existing
medical conditions: lung disease, heart disease, kidney disease,© 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microb
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4liver disease, neurological disease, haematological disease,
autoimmune disease, cancer, diabetes and alcoholism. Statistical
analysis was conducted using STATA v11.2 (College Station, TX,
USA).ResultsStudy patients
A total of 327 patients with sepsis meeting the inclusion criteria
were enrolled. The bacterial isolate was discarded in error for
16 patients and these cases were excluded from the analysis.
Recruitment was highest at Sunpasitthiprasong Hospital
(n = 154), followed by Udon Thani Hospital, Khon Kaen Hos-
pital, and Srinagarind Hospital (n = 99, n = 34 and n = 24,
respectively). Characteristics of the 311 study patients at the
time of enrolment are shown in Table 1. The median age was
53 years (interquartile range 41–65), and 108 (34.7%) were
women. Nearly half of cases (n = 149, 47.9%) had no pre-
existing medical condition, but a third (n = 109, 35.1%) had
diabetes mellitus. In all, 119 patients (38.3%) had documented
staphylococcal bacteraemia at the time of enrolment. Several
patients had positive cultures from multiple sites, in which case
the ﬁrst isolate was obtained for analysis. The types of speci-
mens from which isolates included here were cultured were
abscesses (n = 163, 52.4%), blood (n = 115, 37.0%), bone or
arthocentesis samples (n = 21, 6.8%), body ﬂuids including
peritoneal, pleural, biliary tract and cerbrospinal ﬂuid samples
(n = 7, 2.3%), pus from implanted surgical hardware (n = 3,
1.0%), and pus from spaces such as sinuses and inner ear (n = 2,
0.6%). Anti-staphylococcal therapy was initiated no more than
2 days after cultures were taken in 304 patients (97.7%). A total
of 196 patients (63.0%) underwent a procedure to drain pus.
Sixty-six patients (21.2%) developed respiratory failure or
shock. All-cause mortality was 9% at 28 days, with a higher
death rate in patients with documented bacteraemia at the time
of enrolment (19.3%) or in those who developed respiratory
failure or septic shock (33.3%).
Prevalence of S. argenteus infection
A combination of PFGE and MLST was used to distinguish be-
tween S. argenteus and S. aureus. PFGE was performed on all
311 isolates and MLST was then undertaken for at least one
representative of each of the PFGE banding pattern types. PFGE
revealed 71 different banding patterns, MLST of which resolved
38 STs. The most common STs were ST121 (n = 111, 36%) and
ST2250 (n = 54, 17%), while ST88 and ST97 each comprised 14
(5%) isolates and ST1 comprised 13 (4%) isolates. The
remaining 105 isolates belonged to 33 different STs, seven of
which were novel (ST2966, ST2967, ST2968, ST2969, ST2970,iology and Infectious Diseases, CMI, 22, 458.e11–458.e19
.0/).
TABLE 1. Characteristics of patients with Staphylococcus aureus or Staphylococcus argenteus infections
Variable
All cases
(n [ 311) S. aureus (n [ 253) S. argenteus (n [ 58)
Crude OR (95% CI)
p value
Adjusted OR (95% CI)
p value
Median age, years (IQR) 53 (41–65) 53 (40–65) 56.5 (47–67) 1.01 (0.99–1.03)
0.25
1.01 (0.99–1.03)
0.55
Female, n (%) 108 (34.7) 93 (36.8) 15 (25.9) 0.60 (0.32–1.14)
0.12
0.45 (0.22–0.90)
0.03
Pre-existing conditions, n (%)
Diabetes mellitus 109 (35.1) 84 (33.2) 25 (43.1) 1.52 (0.85–2.73)
0.16
1.57 (0.81–3.05)
0.19
Heart disease 16 (5.1) 10 (4.0) 6 (10.3) 2.80 (0.98–8.06)
0.09
2.19 (0.67–7.21)
0.20
Kidney disease 51 (16.4) 40 (15.8) 11 (19.0) 1.25 (0.60–2.61)
0.56
0.93 (0.38–2.25)
0.87
Liver disease 11 (3.5) 10 (4.0) 1 (1.7) 0.43 (0.05–3.40)
0.42
0.29 (0.03–2.65)
0.28
Lung disease 17 (5.5) 15 (5.9) 2 (3.5) 0.57 (0.13–2.55)
0.46
0.42 (0.08–2.07)
0.29
Cancer 7 (2.3) 5 (2.0) 2 (3.5) 1.77 (0.34–9.37)
0.50
2.64 (0.44–16.00)
0.29
Alcoholism 4 (1.3) 4 (1.6) 0 — —
Autoimmune disease 5 (1.6) 4 (1.6) 1 (1.7) 1.09 (0.12–9.96)
0.94
0.66 (0.06–7.16)
0.74
Neurological disease 8 (2.6) 7 (2.8) 1 (1.7) 0.62 (0.07–5.11)
0.65
0.63 (0.07–5.79)
0.69
Haematological disease 8 (2.6) 5 (2.0) 3 (5.2) 2.71 (0.63–11.66)
0.18
1.67 (0.32–8.72)
0.55
Median co-morbidity index (IQR) 1 (0–1) 1 (0–1) 1 (0–1) 1.23 (0.91–1.68)
0.19
1.16 (0.82–1.63)
0.39
IQR, interquartile range.
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ST239 (the prevalent MRSA clone in Thailand) and the
remaining isolate was a single locus variant of ST239 (ST241). A
maximum likelihood phylogenetic tree based on concatenated
sequences of seven MLST loci divided the collection into two
major branches containing 253 (81%) and 58 (19%) isolates,
respectively (Fig. 1). The branch containing 253 isolates was
deﬁned as S. aureus based on assignment to, or clustering with
previously established S. aureus lineages. The 58 isolates in the
second cluster were all deﬁned as S. argenteus based on
belonging to STs that have been assigned previously to this
species. The S. argenteus branch contained four STs, but the
overwhelming majority (54/58, 93%) belonged to ST2250.
S. argenteus was isolated with varying frequency depending on
the hospital; it accounted for 30% (95% CI 21%–40%) of iso-
lates from Udon Thani Hospital, 25% (95% CI 10%–47%) from
Srinagarind Hospital, 13% (95% CI 8%–19%) from Sunpa-
sitthiprasong Hospital, and 6% (95% CI 1%–20%) from Khon
Kaen Hospital. Mapping the place of residence for patients
infected by each of the two staphylococcal species demon-
strated that patients infected with S. argenteus and S. aureus
were drawn from a comparably broad range of locations across
northeast Thailand (Fig. 2a). All S. argenteus isolates had a white
colony morphology consistent with the lack of staphyloxanthin.
Clinical comparison between S. aureus and S. argenteus
sepsis
To determine whether S. argenteus causes sepsis in different
populations than those infected with S. aureus, we compared© 2016 The Authors. Published by Elsevier Ltd on behalf of Euro
This is an opatient characteristics between the 253 patients with
S. aureus infection and 58 patients with S. argenteus infection
(Table 1). There was no difference in age between the two
groups but S. argenteus infection was less common in females
(adjusted OR 0.45, 95% CI 0.22–0.90, p 0.03). The odds
ratio point estimates suggested that heart disease and cancer
were more common in patients with S. argenteus infection,
although the conﬁdence intervals were wide (adjusted OR
2.19, 95% CI 0.67–7.21, p 0.20, and adjusted OR 2.64, 95%
CI 0.44–16.00, p 0.29). To evaluate the previous suggestion
that S. argenteus may be less virulent than S. aureus, we
compared rates of bacteraemia, treatments and clinical out-
comes between the 58 patients with S. argenteus infection
and 253 patients with S. aureus infection. Bacteraemia was
comparably likely in patients with S. argenteus infection
(32.8% versus 39.5%, adjusted OR 0.65, 95% CI 0.34–1.24, p
0.19). There was no difference in rates of delayed antibiotic
administration (2.8% versus 0.0%, p 0.36) or in rates of
drainage procedures performed in both groups (62.1% vs
63.2%, adjusted OR 1.21, 95% CI 0.63–2.30, p 0.57). Clinical
outcomes are shown in Table 2. S. argenteus infection
precipitated less respiratory failure than S. aureus infection
during hospitalization (5.2% versus 20.2%, adjusted OR 0.21,
95% CI 0.06–0.74, p 0.015) and the odds ratio point estimate
for shock trended in the same direction (6.9% versus 12.3%,
adjusted OR 0.46, 95% CI 0.15–1.44, p 0.18). There was no
difference in the rates of death at 28 days (6.9% versus 8.7%,
adjusted OR 0.80, 95% CI 0.24–2.65, p 0.72) for S. argenteus
and S. aureus, respectively.pean Society of Clinical Microbiology and Infectious Diseases, CMI, 22, 458.e11–458.e19
pen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
FIG. 1. Phylogenetic tree of 311 putative Staphylococcus aureus isolates. The tree is based on concatenated sequences of seven multilocus sequence
typing loci using the maximum likelihood method.
458.e15 Clinical Microbiology and Infection, Volume 22 Number 5, May 2016 CMIBacteriological comparisons between S. argenteus and
S. aureus
A bacteriological comparison was undertaken between the two
staphylococcal species to determine rates of antimicrobial drug
resistance, and the presence of toxin genes found in S. aureus.
The antimicrobial drugs tested were those prescribed at least
once to the study cohort. Rates of resistance to penicillin were© 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microb
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4similar between the two species, but rates of resistance were
notably lower in S. argenteus for the remainder of the drugs
tested (Fig. 2b). Speciﬁcally, S. argenteus resistance was only
observed in a single isolate for two additional drugs (erythro-
mycin and clindamycin). PCR was used to deﬁne the presence
of nine toxin genes in the two species (Fig. 2c). Only two toxin
genes (pvl and seb) were detected in S. argenteus, which wereiology and Infectious Diseases, CMI, 22, 458.e11–458.e19
.0/).
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TABLE 2. Outcomes of patients with Staphlococcus aureus or Staphylococcus argenteus infections
Pathogen
Outcome
Crude OR (95% CI)
p value
Adjusted OR (95% CI)
p valueNo Yes
Respiratory failure
S. aureus 202 (79.8) 51 (20.2) 0.22 (0.06–0.72)
0.012
0.21 (0.06–0.74)
0.015S. argenteus 55 (94.8) 3 (5.2)
Shock
S. aureus 222 (87.8) 31 (12.3) 0.53 (0.18–1.57)
0.25
0.46 (0.15–1.44)
0.18S. argenteus 54 (93.1) 4 (6.9)
Death
S. aureus 231 (91.3) 22 (8.7) 0.78 (0.26–2.36)
0.66
0.80 (0.24–2.65)
0.72S. argenteus 54 (93.1) 4 (6.9)
458.e17 Clinical Microbiology and Infection, Volume 22 Number 5, May 2016 CMIpresent at a frequency of 16% (9/58) and 2% (1/58), respec-
tively. All nine pvl-positive isolates were conﬁrmed by MLST as
ST2250. By comparison, eight of the genes tested were
detected in S. aureus at a variable frequency (Fig. 2c). pvl was
detected in 51% (129/253) of S. aureus, which is consistent with
previous studies based in the same geographical region [22].DiscussionThis study indicates that S. argenteus is an important cause of
community-acquired invasive methicillin-susceptible S. aureus
sepsis in Thailand. Our data suggest an increase in the preva-
lence of invasive, community-acquired S. argenteus infection in
northeast Thailand since 2006/07, when 4% of isolates from 246
unselected patients presenting to Sunpasitthiprasong Hospital
(one of the study hospitals) with invasive putative S. aureus
disease were actually S. argenteus [6]. The basis for this is un-
clear, although we note that S. argenteus sepsis occurred more
often in men and may be associated with occupation or dif-
ferential exposure for other reasons.
Apart from the dominant S. argenteus ST2250, three other
STs—ST2198, ST1223 and ST2854—were also identiﬁed for
this species. These STs have been reported previously from
Cambodia, Australia and French Guiana (ST1223); the UK
(ST2250); Australia and Germany (ST2198); and Thailand
(ST2854) [2,4–6,14]. S. argenteus was previously reported as
the cause of community infections in South East Asia [2],
Australia [3], South America [4] and Europe (http://saureus.
mlst.net/). The most common ST among S. aureus isolates
was ST121, a ﬁnding that is concordant with previous reports
demonstrating that ST121 is common in Thailand [6],
Cambodia [23] and other countries [24–26].FIG. 2. Comparisons between Staphylococcus argenteus and Staphylococcus a
admission. Blue and red dots represent patients infected with S. aureus (n = 253
(c) presence of selected putative virulence genes in S. aureus (n = 253) and S
© 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microb
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4A key objective of this study was to understand whether
there was utility in determining whether a patient with invasive
staphylococcal disease was infected by S. aureus or S. argenteus.
This is unlikely to inﬂuence the choice of antimicrobial treat-
ment since susceptibility testing will dictate prescribing, but
could be important if disease severity was clearly different be-
tween the two. In comparison with individuals with S. aureus
infection, patients with S. argenteus infection may be more likely
to have heart disease or cancer, although we could not establish
this conclusively due to wide conﬁdence intervals around the
odds ratio point estimates. Bacteraemia is often associated with
more severe disease manifestations, but rates of bacteraemia
were comparable between the two groups. There was no dif-
ference in 28-day mortality, yet there was a notably lower rate
of respiratory failure in patients with S. argenteus infection. A
similar trend was observed for septic shock, although this did
not reach statistical signiﬁcance. Importantly, this observational
study was underpowered to detect differences in rates of less
common outcomes such as septic shock and death.
There are several potential explanations for the reduced
respiratory failure in patients with S. argenteus sepsis. This
species is more susceptible to antimicrobial drugs overall, and
may be less likely to be treated with an empiric agent to which
it is resistant. Although biochemical phenotypes and 16S rRNA
sequence are similar to S. aureus, there is approximately 10%
core genome divergence from prototypical S. aureus [14]. A
range of virulence determinants found in S. aureus may be ab-
sent in S. argenteus. S. argenteus lacks staphyloxanthin, a
carotenoid pigment that confers resistance against oxidative
stress and neutrophil killing [27,28]. This observation has led
others to hypothesize that S. argenteus may be less virulent than
S. aureus [14]. A single test isolate of S. argenteus was more
susceptible to oxidative stress and neutrophil killing in vitro andureus. (a) Geographic distribution of patient residence before hospital
) and S. argenteus (n = 58), respectively. (b) Antimicrobial resistance and
. argenteus (n = 58) isolates, in per cent.
iology and Infectious Diseases, CMI, 22, 458.e11–458.e19
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compared with S. aureus [27,28], but this was not fully explained
by the action of staphyloxanthin because the same isolate
expressing the gene encoding staphyloxanthin was more
resistant to oxidative stress in vitro but showed no change in
resistance to neutrophil killing or in vivo virulence [13]. The
majority of S. argenteus were negative for the genes encoding
PVL, although the ﬁnding that this was present in a proportion
of S. argenteus isolates represents the second description of pvl-
positive S. argenteus to our knowledge after a report of two
cases that presented in 2014 [11].
Our results should be interpreted in light of several limita-
tions. We did not enrol patients who died rapidly following
admission, reducing our power to detect associations with
death. Moreover, the total number of patients enrolled was
relatively small, often resulting in wide conﬁdence intervals
around point estimates. Hence, although we have identiﬁed
several important clinical differences in patients with
S. argenteus infection compared with those with S. aureus
infection, we cannot exclude other clinically relevant associa-
tions that our study lacked the power to identify. Furthermore,
most S. argenteus isolates belonged to a single ST, and further
studies are required to compare the two diseases in other
settings where the prevalent lineages of this species differ.
Finally, despite our efforts to control for potential confounding
factors, residual confounding may still exist. However, strengths
of our study are prospective patient enrolment at multiple
centres in northeast Thailand, rigorous enrolment criteria
requiring clinical sepsis attributable to staphylococcal infection,
and more extensive batched analysis of isolates in a central
location.
In conclusion, clinical differences exist in patients who
develop infection with S. argenteus versus S. aureus sepsis.
S. argenteus precipitated signiﬁcantly less respiratory failure than
S. aureus, with a similar but non-signiﬁcant trend for shock. This
may be related to heightened antimicrobial susceptibility of
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